Hope Medicine Inc. announces positive results from a global Phase 2 study of a first-in-class endometriosis treatment and breakthrough therapy designation
October 24, 2024 | 07:08
Hope Medicine Inc, a clinical-stage innovative biopharmaceutical company, announced positive results from an interim analysis of a global Phase 2 study..
Mobile Version